Liu, Jiacong
Zhu, Linhai
Huang, Xuhua
Lu, Zhongjie
Wang, Yanye
Yang, Yuhong
Ye, Jiayue
Gu, Chen
Lv, Wang
Zhang, Chong
Hu, Jian
Funding for this research was provided by:
the National Key Research and Development Program of China (2022YFC2407303)
Major Science and Technology Projects of Zhejiang Province (2020C03058)
Research Center for Lung Tumor Diagnosis and Treatment of Zhejiang Province (JBZX-202007)
Article History
Received: 27 January 2024
Accepted: 11 March 2024
First Online: 27 March 2024
Declarations
:
: The authors have no conflicts of interest to declare.
: This trial was permitted by the Clinical Research Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine (2021 IIT No. 742), and was in line with the Declaration of Helsinki (as revised in 2013) and Good Clinical Practice Guidelines. What’s more, we gained written informed consent from enrolled patients so that we could get access to their electronic medical record information.